On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

hopTo, Inc. (HPTO) Providing a Cost Effective and Secure Solution to Mobile Productivity

hopTo is providing a new standard in mobile productivity through the continued development of its hopTo workspace platform. The company’s proprietary system enables users to search, access, create, edit and share content directly from their mobile devices without compromising enterprise security by saving documents directly to a cloud drive or corporate network. Through its dedication […]

OncoSec Medical, Inc. (ONCS) Pioneering New Platform to Effectively Treat Various Forms of Cancer

OncoSec Medical, Inc. is a biotechnology company pioneering new technologies designed to stimulate the body’s immune system to target and attack cancer. The company is currently conducting preclinical and clinical studies targeting various cancers using its proprietary investigational platform, ImmunoPulse™. Early study results have laid the groundwork for OncoSec’s eventual expansion into new DNA-encoded therapeutic […]

International Stem Cell Corp. (ISCO) Utilizing Revolutionary Technology to Unlock the Power of Regenerative Medicine

An aging population is currently highlighting the considerable limitations of the medical industry. According to the Mayo Clinic, treatments are increasingly unable to keep pace with the needs of patients, with clinicians only having access to medications or devices that can manage symptoms. However, advances in developmental and cell biology, immunology and related fields have […]

GROWBlox Sciences, Inc.’s (GBLX) Advantageous Approach to Medical Cannabis Highlighted at CannabisFN

CannabisFN this morning highlighted GROWBlox Sciences’ role in the cannabis and pharmaceutical industries, paying particular attention to the company’s “unique business model, long-term potential in pharmaceuticals, and short-term potential in raw material sales.” Read the full report here: http://www.marketwatch.com/story/growblox-sciences-takes-integrated-approach-to-cannabis-medicine-2015-05-25?page=1 Twenty three U.S. states and the District of Columbia have legalized marijuana, and according to IBISWorld […]

CytRx Corp. (CYTR) to Present at the Jefferies 2015 Global Healthcare Conference

CytRx Corp., a biopharmaceutical research and development company specializing in oncology, today announced that Steven A. Kriegsman, Chairman and Chief Executive Officer, and David Haen, Vice President of Business Development and Investor Relations, will present a corporate update at the Jefferies 2015 Global Healthcare Conference on Tuesday, June 2, 2015 at 1:30 p.m. Eastern Time. […]

 

From Our Blog

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

April 16, 2021

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort […]

Rotate your device 90° to view site.